Contents hide • ocultar1. Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test.
Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test.
The IMMray PanCan-d test is the first blood test on the market dedicated to the early detection of pancreatic cancer.
“We are extremely pleased to have achieved this important milestone and to be able to launch the first non-invasive, highly accurate blood test that can help detect pancreatic cancer in early stages. The IMMray PanCan-d test meets a huge clinical need and our ambition is to make the test available to individuals in all the high-risk groups for pancreatic cancer. As a first step, we will launch the test for the familial/hereditary high-risk group,” says Patrik Dahlen, Immunovia’s CEO.
— Read on nordiclifescience.org/immunovia-inc-to-begin-patient-testing-in-the-us/
Oxygen Monitor – Oxímetros en AmerExperience.com/HEALTH ❤️
Fingertip Oxygen Monitor – This Device Can Save Your Life
🇪🇨 Seguros Ecuador
🇺🇸 Best seller products for your health – Productos más vendidos para su salud
100 BESTSELLERS - 🇺🇸 USA Health Products on Amazon
What do you get? - The best products from the international online market. Picks from millions of items that fit our customer's desires and needs. You get ready Ideas, You Save Time and Money.
This website contains links and affiliate links to other websites (as an affiliate partner we get commissions paid for the sales made by these websites). Some of those websites may be operated by third parties. As Amazon Associate, we earn from qualifying purchases.